BHP Group Ltd
BHPAbout the company
BHP Group Limited operates as a resources company in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and internationally. The company operates through Copper, Iron Ore, and Coal segments. It also engages in the mining of copper, uranium, gold, zinc, lead, molybdenum, silver, iron ore, cobalt, and metallurgical and energy coal.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
5 / 8
NEUTRAL / FAIL
Median fair value
$25.13
-68.4% vs price
Models with upside
0 / 17
Positive margin of safety
Key risk
No clean pass — all 13 investors flag at least one valuation criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | NEUTRAL | FAIL | BUY · Rank #589 (Top 19%) | PASS | NEUTRAL | NEUTRAL | FAIL | FAIL | FAIL | NEUTRAL | PASS | PASS | NEUTRAL | FAIL | FAIL | FAIL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||
| Margin of Safety | -310.6% | -216.3% | -1710.7% | -155.7% | N/A | -170.6% | -273.0% | -425.4% | -73.6% | -195.0% | -425.0% | -86.6% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-22 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-08-22 Score computed: 2026-11-14 |
Where It Passes
Where It Falls Short
- Valuation0% pass✓ 1✗ 27▾
No clean pass — all 13 investors flag at least one valuation criterion
Net income / market capitalization+4.46%; #1850/6340 (top 29.2%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS40.6x✗Graham<= 15xPrice-to-Book Ratio8.5x✗Graham<= 1.5xP/E x P/B343.50✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)18.12✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value9.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=9.0%, ROC=25.5%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS44.8x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)21.6x✗Dreman< 8xPrice / Book Value per Share8.5x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=44.8x, OE Yield=1.3%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=44.8x, FCF Yield=4.6%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=44.8x, P/B=8.5x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-170.6% (IV=$29.38 vs Price=$79.49)✗Marks>= 20% below intrinsic valuePrice / FCF per Share43.4x✗Ackman<= 25Price vs. Trailing Low167% of trailing low ($47.55)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.2359; #3999/6449 (top 62.0%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS44.8x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E0.10✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share8.71x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.2537; #3540/5247 (top 67.5%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+4.60%; #1657/4519 (top 36.7%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-10.59%; #3471/6202 (top 56.0%)✗OshaughnessyTop 10% of eligible cross-section - Valuation models0% pass✗ 11▾
BHP overvalued: all 11 models price fair value below $79.49 (median $25.13)
Graham fair value$19.36✗Graham-310.6% margin vs $79.49Buffett fair value$25.13✗Buffett-216.3% margin vs $79.49Lynch fair value$4.39✗Lynch-1710.7% margin vs $79.49Greenblatt fair value$31.09✗Greenblatt-155.7% margin vs $79.49Dreman fair value$29.38✗Dreman-170.6% margin vs $79.49Munger fair value$21.31✗Munger-273.0% margin vs $79.49Pabrai fair value$15.13✗Pabrai-425.4% margin vs $79.49Akre fair value$45.80✗Akre-73.6% margin vs $79.49Marks fair value$26.95✗Marks-195.0% margin vs $79.49Ackman fair value$15.14✗Ackman-425.0% margin vs $79.49Templeton fair value$42.60✗Templeton-86.6% margin vs $79.49 - Profitability25% pass✓ 18✗ 17▾
12 of 16 flag BHP's profitability — Graham, Buffett, Lynch +9 more
Net income / market capitalization+4.46%; #1850/6340 (top 29.2%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)9/11 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthNet Income Positive (10+ years)9/11 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)31.3%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)38.0% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$5.2B✓BuffettPositive and growingEarnings Variance (10-yr CoV)0.96✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)18.12✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR2.5%✓Lynch15-30% (Fast Grower); > 0% to passROE18.9%✓Lynch> 15%EBIT / Enterprise Value9.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=9.0%, ROC=25.5%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets8.29%✓PiotroskiROA > 0ROA Change YoY7.71% -> 8.29% (delta: +0.58%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=17.18%, ROA=8.29%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY✗PiotroskiImproved YoYPre-Tax Income / Revenue35.8%✓Dreman>= 8%Net Income / Shareholders' Equity18.9%✓Dreman> 12%Margin of SafetyP/E=44.8x, P/B=8.5x✗PabraiP/B < 1.5 or P/E < 15Return on Equity21.9% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value-170.6% (IV=$29.38 vs Price=$79.49)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency9/10 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue38.0%✓Ackman>= 15%Net Income / Shareholders Equity18.9%✓Ackman>= 15%5-Year EPS CAGR2.5% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend42.6% (2022) -> 38.0% (2024)✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendrevenue flat/down, operating margin 42.6% -> 38.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+18.92%; #845/5226 (top 16.2%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0925; #3376/5884 (top 57.4%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR2.5% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years9/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts33% pass✓ 4✗ 8▾
Split decision: 8 FAIL · 5 NEUTRAL · 3 PASS
Overall verdict✗GrahamFAIL (1/9)•BuffettNEUTRAL (6/9)✗LynchFAIL (2/7)✓GreenblattRank #589✓PiotroskiPASS (F-Score 5)•DremanNEUTRAL (7/11)•MungerNEUTRAL (3/4)✗PabraiFAIL (1/3)✗AkreFAIL (2/6)✗MarksFAIL (3/5)•AckmanNEUTRAL (6/9)✓TempletonPASS (4/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✗SchlossFAIL (3/7)✗OshaughnessyFAIL (Rank #547/963 (Top 56.8%)) - Growth38% pass✓ 6✗ 7▾
5 of 8 flag BHP's growth — Graham, Lynch, Ackman +2 more
EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)18.12✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR2.5%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -5.0% vs Rev: -7.9%✗LynchInventory growth < Revenue growthEPS Growth Direction$-1.20 (2015) -> $1.77 (2024)✓DremanPositive over recent yearsEPS CAGR6.1% CAGR over 8 years✓Dreman> 5% annualizedPositive Net Income Frequency9/10 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-7.9%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR2.5% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendrevenue flat/down, operating margin 42.6% -> 38.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR5.7%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR2.5% over 5 years✗Neff7%-20% annualized - Debt & Leverage50% pass✓ 8✗ 7▾
6 of 12 pass — Graham, Lynch, Dreman +3 more object
Debt Levels0.45✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.45, IC: 11.0x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.45✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.46✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.45✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xInterest Coverage & Debt/EBITDAIC=11.0x, D/EBITDA=0.9x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.45✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.4520; #2370/4210 (top 56.3%)✗AsnessTop 30% of eligible cross-section - Cash Flow50% pass✓ 6✗ 6▾
5 of 10 pass — Lynch, Dreman, Pabrai +2 more object
Free Cash Flow Proxy$5.2B✓BuffettPositive and growingFCF Positive and Growing$9.3B✗LynchPositive and growingOperating Cash Flow$18.7B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=17.18%, ROA=8.29%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)21.6x✗Dreman< 8xP/E or FCF YieldP/E=44.8x, FCF Yield=4.6%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive10/10 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap2.3%✗Ackman>= 4%Price / FCF per Share43.4x✗Ackman<= 25Positive Operating Cash Flow frequency10/10 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$9.3B✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+4.60%; #1657/4519 (top 36.7%)✗OshaughnessyTop 10% of eligible cross-section - Efficiency50% pass✓ 6✗ 5▾
4 of 8 pass — Graham, Piotroski, Dreman +1 more object
Current Ratio1.46✗Graham>= 2.0ROIC (3-5 yr avg)32.9%✓Buffett> 10%ROIC - WACC+22.9%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)25.5%✓Greenblatt> 25%Current Ratio Change YoY1.70 -> 1.46✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.54x -> 0.47x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.46✗Dreman> 1.5Return on Invested Capital22.2%✓Munger> 15%ROIC (high and growing)FY2022: ROIC=28.4%; FY2023: ROIC=22.2%; FY2024: ROIC=22.2%✓AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC2.1% (RR=10% x ROIC=22.2%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)5/5 years above 12% (latest 22.2%)✓SleepROIC > 12% in a majority of years
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Issued 0.1% of shares last year, 0.2% issued over two.
- Buybacks
- —
- Dividends
- $8.2B
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
| FY 2020Sources
|
|---|---|---|---|---|---|
| Market Cap | $202.0Bcurrent | $283.1Best. | $306.2Best. | $221.7Best. | $124.1Best. |
| Revenue | $51.3B↓8% | $55.7B↑3% | $53.8B↓17% | $65.1B↑14% | $56.9B |
| Operating Income | $19.5B↑11% | $17.5B↓24% | $22.9B↓33% | $34.1B↑34% | $25.5B |
| Net Income | $9.0B↑14% | $7.9B↓39% | $12.9B↓58% | $30.9B↑173% | $11.3B |
| EPS (Diluted) | $1.77↑14% | $1.55↓39% | $2.55↓58% | $6.09↑173% | $2.23 |
| Gross Margin | — | — | — | — | — |
| Operating Margin | 38.0%↑21% | 31.5%↓26% | 42.6%↓19% | 52.4%↑17% | 44.8% |
| ROE | 18.9%↑7% | 17.6%↓39% | 29.0%↓58% | 68.7%↑212% | 22.1% |
| Total Debt | $21.5B↑22% | $17.6B↓9% | $19.3B↑40% | $13.9B↓19% | $17.1B |
| Shareholders' Equity | $47.7B↑6% | $44.8B↑1% | $44.5B↓1% | $45.0B↓12% | $51.3B |
| Current Ratio | 1.46↓14% | 1.70↑39% | 1.23↓28% | 1.69↑4% | 1.63 |
| Debt / Equity | 0.45↑15% | 0.39↓10% | 0.43↑41% | 0.31↓8% | 0.33 |
| Operating Cash Flow | $18.7B↓10% | $20.7B↑11% | $18.7B↓42% | $32.2B↑18% | $27.2B |
| Free Cash Flow | $9.3B↓22% | $11.8B↓1% | $12.0B↓55% | $26.3B↑22% | $21.6B |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Non-Metallic Mining
BHP vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOUTHERN COPPER CORP/SCCO | $140.0B | $164.08 | $13.4B | $4.3B | 39.4% | 0.61 | 52.2% | 3.89 | 4/9 | 5/9 | 4/7 | 1/3 | F-Score 7 | 5/11 |
| FREEPORT-MCMORAN INCFCX | $85.0B | $59.24 | $25.9B | $4.2B | 22.0% | 0.50 | 25.2% | 2.29 | 2/9 | 5/9 | 3/7 | 0/3 | F-Score 5 | 7/11 |
| Vale S.A.VALE | $47.7B | $11.22 | $38.4B | $2.4B | 7.0% | 0.02 | 15.4% | 1.15 | 1/9 | 4/9 | 2/7 | 1/3 | F-Score 3 | 4/11 |
| MARTIN MARIETTA MATERIALS INCMLM | $36.5B | $513.61 | $6.2B | $1.1B | 11.3% | 0.53 | 23.4% | 3.57 | 4/9 | 3/9 | 1/7 | 0/3 | F-Score 8 | 7/11 |
| Vulcan Materials COVMC | $35.8B | $278.63 | $7.9B | $1.1B | 12.6% | 0.51 | 20.4% | 2.69 | 2/9 | 2/9 | 2/7 | 0/3 | F-Score 9 | 5/11 |
| CAMECO CORPCCJ | $30.8B | $70.73 | $2.5B | $430.5M | 8.5% | 0.14 | 17.8% | 2.47 | 3/9 | 3/9 | 5/7 | 0/3 | F-Score 8 | 6/11 |
| TECK RESOURCES LTDTECK | $29.6B | $60.19 | $7.9B | $1.0B | 5.6% | 0.16 | 20.9% | 2.54 | 3/9 | 2/9 | 2/7 | 0/3 | F-Score 8 | 4/11 |
| HECLA MINING CO/DE/HL | $8.8B | $13.10 | $1.4B | $321.7M | 12.4% | 0.10 | 36.2% | 2.72 | 3/9 | 2/9 | 5/7 | 0/3 | F-Score 8 | 5/11 |